These success, along with a past report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two help the strategy of focusing on ACKR3 as a novel approach to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-associated Conditions. In reaction to this https://bertoltl394bri0.wikitron.com/user